A Trial of KB004 in Patients With Glioblastoma

NCT03374943 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Glioblastoma

Interventions

DRUG: KB004

Sponsor

Olivia Newton-John Cancer Research Institute

Collaborators

[object Object]